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https://doi.org/10.1016/j.stemcr.2017.10.030SUMMARYmiR-184 is a highly evolutionary conserved microRNA (miRNA) from fly to human. The importance of miR-184 was underscored by the
discovery that pointmutations inmiR-184 gene led to corneal/lens blinding disease. However,miR-184-related function in vivo remained
unclear. Here, we report that themiR-184 knockoutmousemodel displayed increased p63 expression in line with epidermal hyperplasia,
while forced expression of miR-184 by stem/progenitor cells enhanced the Notch pathway and induced epidermal hypoplasia. In line,
miR-184 reduced clonogenicity and accelerated differentiation of human epidermal cells. We showed that by directly repressing cytoker-
atin 15 (K15) and FIH1,miR-184 induces Notch activation and epidermal differentiation. The disease-causingmiR-184C57Umutant failed
to repress K15 and FIH1 and to induce Notch activation, suggesting a loss-of-function mechanism. Altogether, we propose that, by
targeting K15 and FIH1, miR-184 regulates the transition from proliferation to early differentiation, while mis-expression or mutation
in miR-184 results in impaired homeostasis.INTRODUCTION
The skin and cornea serve as a barrier that is protecting our
body against exterior insults. The outermost layer of both
tissues is a stratified squamous epithelium that is continu-
ously regenerated by stem cells (SCs) during homeostasis
(Blanpain and Fuchs, 2006; O’Callaghan and Daniels,
2011). It was traditionally believed that the interfollicular
epidermis (IFE) is renewed by SCs or a pool of progenitors
that reside in the basal layer, a niche that provides localized
signals to maintain stemness (Fuchs, 2009; Morrison and
Spradling, 2008; Ordonez and Di Girolamo, 2012). Accord-
ingly, cells that exit the niche and transit to the spinous
epidermal layer undergo commitment to the terminal dif-
ferentiation. Similar to the IFE, hair-follicle SCs (HFSCs)
and limbal SCs (LSCs) that regenerate the corneal epithe-
lium are located in discrete niches and engage similar dif-
ferentiation programs (Amitai-Lange et al., 2015; Cotsarelis
et al., 1989, 1990; Di Girolamo et al., 2015).
The classical dogma describes epidermal SCs as slow-
cycling cells that are rare in the niche, surrounded by
ten fast-dividing but short-lived progenitor cells (Mascre
et al., 2012; Potten et al., 1974). This deterministic para-
digm can explain the heterogeneity of basal epidermal cells
in vivo and ex vivo; however, against this dogma, there are
no specific markers that label specifically slow-cycling
SCs. An alternative stochastic model suggests that theStem Cell Report
This is an open access artientire basal layer is occupied by equipotent fast-dividing
progenitor cells that compete for niche factors for survival
(Clayton et al., 2007; Rompolas et al., 2016; Bacman et al.,
2013). In light of this controversy, it would be important
to clarify the mechanisms of SC regulation and the sharp
switch from proliferative to post-mitotic compartment,
which is only partially understood.
p63 plays a key role in themaintenance of epidermal pro-
liferation and stemness (Blanpain and Fuchs, 2007; Senoo
et al., 2007) while Notch represses p63 and cell prolifera-
tion and activates a cell epidermal differentiation program
(Rangarajan et al., 2001; Nguyen et al., 2006). The antago-
nizing role of p63 and Notch is common to the differenti-
ation programs of epidermis, hair follicle, and cornea. In
line, p63-null mice fail to develop all types of stratified
epithelia (Mills et al., 1999; Shalom-Feuerstein et al.,
2011; Yang et al., 1999) while Notch1-deficient mice
display epidermal hyperplasia and aberrant differentiation
(Rangarajan et al., 2001). However, while the function and
molecular cues controlled by p63 and Notch are well
described in the literature, very little is known regarding
the signals that regulate p63 and Notch expression or
activity.
MicroRNAs (miRNAs) play a role in regulating diverse
biological processes, including SC maintenance and differ-
entiation. However, accumulating reports suggest that
most miRNA knockout mouse strains displayed mild ors j Vol. 9 j 1991–2004 j December 12, 2017 j ª 2017 The Authors. 1991
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no phenotype, unless stress was applied (Park et al., 2010).
In line, only few miRNA encoding genes were associated
with human genetic diseases. miR-184 is a remarkably
evolutionary conserved miRNA, which was shown to be
essential for the commitment of embryonic stem cells
into corneal-epithelial cells (Shalom-Feuerstein et al.,
2012). miR-184 was shown to be involved in various bio-
logical processes, including germline development in the
fly (Iovino et al., 2009), neural fate (Liu et al., 2010;
Nomura et al., 2008), cell proliferation, and migration (Yu
et al., 2008, 2010). Interestingly, four different point muta-
tions in miR-184 were linked with lens/corneal dystrophy
and blindness (Farzadfard et al., 2016; Hughes et al.,
2011; Lechner et al., 2013; Iliff et al., 2012). However, the
different functions of miR-184 in vivo under homeostasis
and the etiology of miR-184-related eye pathology re-
mained to be investigated.
Here, we report that the level of miR-184 is significantly
elevated in committed cells of the epidermis, hair follicle,
and corneal epithelium. By generating loss-of-function
and gain-of-function mouse models, we found that miR-
184 controls the balance between epidermal cell prolifera-
tion and differentiation. The molecular mechanism in-
volves direct repression of K15 and FIH1, induction of
Notch pathway, and cell differentiation.RESULTS
Compartmentalized Expression Pattern of miR-184
Atmurine embryonic day 11.5 (E11.5), miR-184was highly
expressed in the developing lens (Figure 1A, arrowhead)
while from E14.5–18.5 to postnatal stages, a significant
signal was detected in the developing epidermis and hair
follicles (Figures 1A and 1B). Low or no signal was found
in the epidermal basal layer cells at E18.5 and postnatal
day 8 (P8) (Figure 1B, high magnification, white arrow).
However, a clear signal was found in the spinous layer
(red arrow) and no signal was evident in late terminally
differentiated cells (green arrow) (Figures 1B and S1). Like-
wise, miR-184 was not expressed in the hair-follicle SC
niche (bulge) but was detected in early committed outer
root sheath cells (ORS) and matrix cells and not expressed
by terminally differentiated hair shaft cells (Figure 1B, see
also Figures 5B and 5C). In contrast to the epidermis,
corneal stratification begins after birth, and SC niche func-
tion was demonstrated by lineage tracing of 2-month-old
mice (Amitai-Lange et al., 2015; Di Girolamo et al., 2015).
At P60,miR-184 was expressed at low levels in the SC niche
(limbus, white arrow), highly induced in early committed
basal layer peripheral and central corneal epithelium (red
arrow) but not by terminally differentiated (K12-express-
ing) corneal supra-basal cells (green arrow) (Figure 1C). To1992 Stem Cell Reports j Vol. 9 j 1991–2004 j December 12, 2017further explore the specificity of miR-184 expression in
epidermal cells we performed in situ hybridization and
real-time PCR analysis. We confirmed that miR-184 is
expressed in the epidermis of wild-type and not miR-184-
deficient epidermis (Figures S2E–S2F), miR-184 is expressed
by primary human and mouse keratinocytes (KCs) and
repressed by anti-miR antagonist (Figure S2G) and is
expressed in heart, epidermal, and corneal cells but not
in fibroblasts (Figure S2H). Altogether, miR-184 displays a
common expression pattern in the differentiation program
of the epidermis, hair follicle, and corneal epithelium; it
is low or absent in the SC compartment, high in early
committed cells, and absent in terminal differentiated
cells.
Modulation of miR-184 Expression in Mice Results in
Abnormal Epidermal Proliferation
To investigate the importance ofmiR-184 in vivo, amiR-184
knockout (KO) mouse model carrying a conditional loss-
of-function allele was generated. These mice were crossed
with a ubiquitously expressed Cre transgene (ROSA26-
Cre) to generate miR-184-heterozygous (HT) mice (Figures
S2A–S2B). Genotyping, quantitative real-time PCR, and
in situ hybridization analyses confirmed that miR-184 is
not expressed by KO mice (Figures S2C, S2E, and S2F).
Although the number of HT and KO newborn pups was
lower than expected from the Mendelian ratio, this differ-
ence was not statistically significant (chi-squared test
p value 0.2518, n = 255, Figure S2D). No gross phenotype
was observed in HT and KO mice, which macroscopically
appeared comparable with wild-type (WT) control mice
and were fertile. Eye phenotypes will be described
elsewhere.
Histology of newbornmice showed a significant increase
in epidermal thickness in KO mice compared with WT
counterparts (Figures 2A and 2B). In line, an increased
number of proliferating Ki67-positive cells was observed
in miR-184-null epidermis, indicating that miR-184 re-
presses cell proliferation (Figures 2A and 2C). In agreement,
ablation of miR-184 resulted in a reduction in the percent-
age of epidermal cells in G1 and an increase in cells found
to be in S and G2/M phase (Figures 2D, S3A, and S3B).
Although miR-184 is expressed by hair-follicle cells, no
change was found in hair-follicle morphology and cell pro-
liferation. To investigate whether the thickening of the
epidermis is associated with a specific layer, we performed
staining of K14 (basal layer), K10 (spinous layer), and Filag-
grin (cornified layer). All epidermal layers were present in
the miR-184-null mice; however, the spinous K10-positive
cell layer was significantly thicker (30% increase) (Figures
2E and 2F). The changes in proliferation and thickening of
the spinous layer raised the possibility that the switch from
the basal layer to the spinous layer, which is known to be
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Figure 1. Expression Profile of miR-184
in the Murine Skin and Cornea
In situ hybridization was performed on
whole embryos (A) or tissue sections
(B and C) of wild-type mice on the indicated
embryonic day (see also Figures 5B and 5C).
(A) Signal of miR-184 was evident in the
developing lens at E11.5 (arrowhead) while
at E14.5, the levels of miR-184 increased in
the epidermis and hair follicles. At E18.5
and P8 (B), most epidermal basal cells ex-
pressed low levels of miR-184 (white arrow),
while miR-184 was highly expressed in the
spinous layer (red arrow) but not in termi-
nally differentiated cells (green arrow).
Inset in (B) is the enlarged epidermal region
shown for E18.5. In the hair follicle (B, right
image), miR-184 was not detected in the
bulge SC niche (white arrow), expressed by
early committed inner root sheet (red ar-
row), and matrix cells but not in terminally
differentiated hair cells (green arrow).
(C) Mouse cornea at P60 showed a similar
pattern of low signal of miR-184 in the SC
niche (limbus, white arrow, defined K14
staining of the adjacent section in the lower
panel), early committed corneal basal
epithelial cells expressed high levels (red
arrow), while terminally differentiated
corneal supra-basal cells (green arrow, K12-
positive, compare with lower panel) were
negative. The dashed lines indicate the
dermal-epidermal (B) and corneal stromal-
epithelial (C) junction. Scale bars, 50 mm.
der, dermis; ep, epithelium; st, stroma.controlled by p63 (Senoo et al., 2007) and Notch (Nguyen
et al., 2006; Rangarajan et al., 2001), is interrupted in miR-
184 knockout skin. Indeed, the levels of p63 increased
while the levels of active Notch (NICD) and its downstream
target genes, Hes1 andHey2, decreased (Figures 2E, 2G, and
2H). Since miR-184 is low or not expressed by basal cells
(Figure 1B), the effect on the basal layer may involve a
non-cell-autonomous mechanism. However, low signal
was evident sometimes and a cell-autonomous effect could
not be excluded (see Discussion). The expression of miR-
184 in early committed spinous cells, together with its
impact on proliferation and the Notch pathway, suggests
that miR-184 may serve as a molecular switch to epidermal
differentiation. In line, primary KCs that were subjected toa clonogenicity test have shown increased colony-forming
potential, compared with their wild-type counterparts (Fig-
ures 2I and 2J). To test this hypothesis further, a transgenic
mouse strain allowing tetracycline-inducible expression of
miR-184 under the promoter of K14 has been produced
(Figures S4A and S4B). Administration of the tetracycline
analog doxycycline (Dox) from E12 efficiently induced
miR-184 only in double-transgenic animals (K14-rtTA;
miR-184Tg, referred to hereafter as Tg) (Figure S4C). Since
no phenotypic difference was found between other geno-
typed littermates (WT, K14-rtTA, or miR-184Tg), K14-rtTA
was used as a control in the next experiments. Newborn
Tg pups that were induced by Dox displayed significant
epidermal hypoplasia coupled to reduced cell proliferationStem Cell Reports j Vol. 9 j 1991–2004 j December 12, 2017 1993
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Figure 2. miR-184-Deficient Mice Dis-
played Increased Proliferation and
Epidermal Hyperplasia
(A–C and E) Paraffin sections of the head of
newborn mice of the indicated genotypes
were used for histology staining with H&E
(A) or for immunofluorescent staining of the
indicated proteins (A and E). Lower histol-
ogy pictures in (A) are enlargements of the
upper panels. Quantification of epidermal
thickness (B) and the percentage of Ki67-
positive basal layer cells (C) were performed
as detailed in the Experimental Procedures.
(D) Cell-cycle analysis of cells that were
freshly isolated from the epidermis of the
indicated genotypes.
(F) Quantification of K14- and K10-positive
cells was performed as detailed in the
Experimental Procedures.
(G) Protein lysates were prepared from the
epidermis of newborn mice of the indicated
genotypes and used for western blot ana-
lyses of the indicated proteins. Values
represent densitometry analysis of three
independent experiments, as detailed in the
Experimental Procedures.
(H) RNA extraction of the epidermis of
newborn mice of the indicated genotypes
was used for quantitative real-time PCR an-
alyses of the indicated genes.
(I and J) KCs were isolated from the
epidermis of newborn mice of the indicated
genotypes, subjected to clonogenicity test,
and visualized by Rhodamine staining (I).
Quantification by computerized analysis is
shown in (J).
Data shown are means ± SD from three in-
dependent experiments. *p < 0.05 statisti-
cally significant by Student’s t test. The
dashed lines (A and E) indicate the dermal-epidermal junction. Quantification of western blot analysis from three independent experi-
ments (p < 0.05) is shown at the bottom of each panel. Scale bars are 50 mm. de, dermis; ep, epidermis.compared with control pups (Figures 3A–3C). This was
mainly due to thinning of the K10-positive spinous layer
(Figures 3D and 3E). Importantly, the levels of p63
decreased while the Notch pathway was enhanced in Tg
animals (Figures 3D, 3F, and 3G). Altogether, these data
indicate that miR-184 tilts the balance between Notch
and p63 in the epidermis, represses epidermal cell prolifer-
ation, and may be involved in early steps of epidermal
commitment to differentiation.
miR-184 Modulates Colony Formation Capacity and
Accelerates Differentiation of Human Keratinocytes
To test the potential effect of miR-184 on long-term pro-
liferation of stem/progenitor cells in human cells, foreskin1994 Stem Cell Reports j Vol. 9 j 1991–2004 j December 12, 2017KCs were transfected with pre-miR-184 mimic (PM184),
anti-miR-184 antagonist (AM184), or control oligonucleo-
tides (Ctl-PM and Ctl-AM, respectively). Forty-eight hours
later, transfectants were seeded at low density, and
their colony formation ability was examined following
2–3 weeks of growth in culture. As shown in Figures 4A
and 4B, the number and size of the clones was largely
reduced following PM184 transfection, while transfection
with AM184 antagonist resulted in enhanced clonogenic
potential. The involvement of miR-184 in SC regulation
and differentiation was further tested by a calcium
stratification/differentiation assay. KC differentiation
was validated by real-time PCR analysis, showing a
decrease in stem/progenitor cell markers and increase in
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Figure 3. Forced Overexpression of miR-184 Attenuated Proliferation and Induced Epidermal Hypoplasia
(A–D) Paraffin sections of the head of newborn mice of the indicated genotypes were used for histology staining with H&E (A) or for
immunofluorescent staining of the indicated proteins (A and D). Lower histology pictures in (A) are enlargements of the upper panels.
Quantification of epidermal thickness (B) and the percentage of Ki67-positive basal layer cells (C) were performed as detailed in the
Experimental Procedures.
(E) Quantification of K14- and K10-positive cells was performed as detailed in the Experimental Procedures.
(F) Primary KCs were extracted from newborn miR-184 transgenic mice, induced with Dox (+) or vehicle () for 48 hr, and subjected to
western blot analysis for p63, NICD, or ERK as loading control. Values represent densitometry analysis of three independent experiments,
as detailed in the Experimental Procedures.
(G) RNA extraction of the epidermis of newborn mice of the indicated genotypes was used for quantitative real-time PCR analyses of the
indicated genes.
Data shown are means ± SD from three independent experiments. *p < 0.05 statistically significant by Student’s t test. The dashed lines
(A and D) indicate the dermal-epidermal junction. Quantification of western blot analysis from three independent experiments (p < 0.05) is
shown at the bottom of each panel. Scale bars are 50 mm. de, dermis; ep, epidermis.differentiation markers over time (Figure 4C). In line with
the expression pattern of miR-184 in vivo, differentiation
was correlated with an elevation in the levels of expres-
sion of miR-184 (Figure 4D). Forced expression of
PM184 mimic induced a decrease in markers of basal layer
cells and an increase in markers of differentiation,compared with control transfection, while AM184 antag-
onist displayed a reciprocal effect (Figure 4E). Interest-
ingly, transfection with pre-miR that mimics the disease-
causing miR-184 (C57U) had no significant effect on
differentiation (Figure 4E), suggesting a loss-of-function
mechanism. Altogether, these data suggest that miR-184Stem Cell Reports j Vol. 9 j 1991–2004 j December 12, 2017 1995
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Figure 4. miR-184 Repressed the Clonogenic Potential and Accelerated Epidermal Differentiation
(A and B) Primary human foreskin KCs were transfected with pre-miR-184-mimic (PM184) or anti-miR antagonist (AM184) or appropriate
controls (Ctl-PM and Ctl-AM, respectively) and then subjected to the clonogenicity test. Colonies were visualized by Rhodamine staining
(A, examples of two experiments are shown) and quantification by computerized analysis is shown in (B).
(C and D) Primary human KCs were induced to differentiate/stratify by high calcium, and quantitative real-time PCR analysis of the
indicated genes was performed to validate differentiation efficiency (C) and TaqMan assay to test the expression of miR-184 (D).
(E) Primary KCs were transfected with PM184 mimic, or with disease-causing pre-miR-184-mutant (C57U) mimic or antagonist (AM184), or
the appropriate control oligonucleotides, and then subjected to calcium-induced stratification/differentiation. Real-time PCR analysis
was performed to evaluate the effect of transfection on differentiation.
Data shown are means ± SD from three independent experiments. *p < 0.05 statistically significant by Student’s t test.
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Figure 5. FIH1 and K15 Are Direct Targets of miR-184 that Maintain Epidermal Stemness In Vitro
(A) HEK293 cells were co-transfected with the indicated concentration (nM) of pre-miR-184 (PM184), disease-causing pre-miR-184C57U
mutant (C57U) or pre-miR-203 (PM203), or control oligonucleotides together with luciferase plasmids containing the 30UTR of the
indicated genes downstream to the luciferase encoding sequence. Cells were lysed 24 hr later and the luciferase assay was performed as
detailed in the Experimental Procedures.
(B and C) In situ hybridization of miR-184 coupled with K15 immunostaining on mouse head cryosections at P0 (B) and P8 (C). Higher
magnification pictures of (C) are shown in (i) and (ii).
(D) Immunofluorescent staining of K15 on mouse sections of newborn mice of the indicated genotypes. Arrows show abnormal expression
of K15 in supra-basal cells of KO mice.
(E) Primary KCs of the indicated genotypes were lysed and subjected to western blot analysis for K15, FIH1, or ERK as loading control.
(legend continued on next page)
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inhibits SC/progenitor clonogenic potential and induces
differentiation in human KCs.
Identification of miR-184 Target Genes in the
Epidermis
To unravel miR-184 pathways in the skin, we used three al-
gorithms (TargetScan, miRanda, MicroCosm) that identify
potential target genes for miRNAs based on complemen-
tary sequences of given miRNA to the 30-untranslated re-
gion (30UTR) of mRNAs. Among other genes, p63, K15,
and FIH1 were very interesting candidates that contained
a predicted binding site(s) for miR-184 (Figure S5A). p63
and K15 were linked with stemness in the skin and cornea
(Ito et al., 2005; Peng et al., 2012; Senoo et al., 2007), and
p63 was modulated by miR-184 (Figures 2 and 3). FIH1
has already been reported to be a direct target of miR-184
in glioma (Yuan et al., 2014) and to negatively regulate
Notch activity (Peng et al., 2012), but its role in the
epidermis is not clear. We thus tested the possibility that
miR-184 can directly bind to the 30UTR of these three genes
by the luciferase assay (Figure S5B). HEK293 cells were co-
transfected with a plasmid containing a luciferase coding
sequence upstream to the 30UTR of p63 (p63-Luc) and
PM184 mimic or non-specific oligonucleotides as control
(Ctl-PM). As shown in Figure 5A, only a mild decrease in
the luciferase activity was observed in the presence of
PM184 mimic. In contrast, miR-203 mimic (PM203), a
known direct repressor of p63 (Lena et al., 2008; Yi et al.,
2008), showed significant inhibition (Figure 5A). This sug-
gests that miR-184 does not directly inhibit p63, and we
conclude that the observed repression of p63 by miR-184
(Figures 2, 3, and 4) was indirect, potentially a consequence
of Notch activation. Notably, PM184 inhibited the lucif-
erase activity when co-transfected with Luc-K15 plasmid,
while point mutation in the 30UTR plasmid (Luc-K15-
mut, Figure S5B), which disrupted the miR-184-predicted
binding site, completely abolished the effect of PM184 (Fig-
ure 5A). In line with a previous report (Peng et al., 2012),
miR-184 efficiently inhibited luciferase activity when co-
transfected with Luc-FIH1. Interestingly, disease-causing
C57U-miR-184mimic did not significantly affect luciferase
activity when co-transfected with Luc-K15 or Luc-FIH1
plasmids (Figure 5A). In situ hybridization of miR-184(F) KCs were transfected with endoribonuclease-prepared silencing RN
Lysates were prepared 48 hr later for immunoblotting against the ind
(G and H) Primary human foreskin KCs were transfected with the indi
Colonies were visualized by Rhodamine staining (G, examples of two ex
is shown in (H).
Data shown are means ± SD from three independent experiments. *p
western blot analysis from at least three independent experiments (p <
indicates the dermal-epidermal junction. Scale bars are 50 mm for (B) a
outer root sheath.
1998 Stem Cell Reports j Vol. 9 j 1991–2004 j December 12, 2017coupled to K15 immunostaining illustrated that miR-184
and K15 are reciprocally expressed in the epidermis and
hair follicle (Figures 5B and 5C), with only scarce co-expres-
sion in the same cells. In agreement, the levels of K15
significantly decreased upon miR-184 forced expression
and increased upon miR-184 ablation (Figures 5D and
5E). Finally, as the available FIH1 antibodies could not
faithfully detect FIH1 protein by staining on tissue
sections, we performed western blot analysis, which
confirmed thatmiR-184 significantly repressed FIH1 in vivo
(Figure 5E). Taken together, these results suggest that miR-
184 directly represses both K15 and FIH1 in the epidermis
in vivo.
The repression of FIH1 or K15 could contribute to
miR-184-observed functions; however, the role of K15
and FIH1 in the KC proliferation and differentiation is un-
known. For efficient and specific gene repression, we used
an endoribonuclease-prepared mixture of siRNA against
each gene or against green fluorescent protein (GFP) as
control. As shown in Figure 5F, repression of either K15
or FIH1 resulted in a decrease in p63 and elevation of early
differentiation genes (NICD, K10). Furthermore, similar to
the effect of miR-184 on the long-term proliferation of KCs
(Figures 4A and 4B), repression of K15 or FIH1 resulted
in significant reduction in KC clonogenicity (Figures 5G
and 5H). Altogether, these data suggest that by repressing
K15/FIH1, miR-184 induces a differentiation program
through Notch activation.
miR-184 Induced Differentiation through Activation
of Notch Signals
In order to examine further the regulation ofNotch bymiR-
184, we performed staining of NICD on wild-type mice
(Figures 6A and 6B). In line with a previous report (Blan-
pain et al., 2006) and similar to miR-184 (Figures 1B, 5B,
and 5C), Notch activity was high in the spinous layer cells,
which are post-mitotic, and in matrix cells, which are
highly proliferative cells. There was no impact on hair
growth in miR-184 mutants, suggesting that miR-184/
Notch is not involved in the regulation of matrix cell pro-
liferation. We next explored the impact of the miR-184/
Notch axis on differentiation. KCs that were transfected
with PM184 mimic showed increased levels of NICD whileAs against K15 (siK15) or FIH1 (siFIH1) or GFP (siGFP) as control.
icated proteins.
cated silencing RNAs and then subjected to the clonogenicity test.
periments are shown), and quantification by computerized analysis
< 0.05 statistically significant by Student’s t test. Quantification of
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Figure 6. miR-184 Activates the Notch
Pathway to Induce KC Differentiation
(A and B) Paraffin sections of wild-type mice
at the indicated postnatal day were stained
for NICD. Scale bars, 50 mm.
(C) KCs were transfected with pre-miR-
184 mimic (PM184), miR184-antagonist
(AM184), or the appropriate control (Ctl-PM
and Ctl-AM, respectively) and harvested
after 48 hr for western blot analysis of the
indicated genes.
(D) KCs were co-transfected with a Notch
activity reporter plasmid (Hes1-dGFP) and
PM184 mimic or miR-184 mutant mimic
(C57U) or antagonist (AM184). Forty-eight
hours later, cells were trypsinized, and the
frequency of GFP-positive cells was quanti-
fied by flow cytometry. Data represent the
fold increase in GFP-positive cells compared
with control transfectants.
(E and F) KCs were co-transfected with
PM184 or control (Ctl-PM) and, on the next
day, treated with the g-secretase inhibitor
that is required for Notch activation (DAPT) or vehicle (DMSO). After 48 hr, cells were subjected to western blot (E) or quantitative real-
time PCR (F) analyses of the indicated genes and proteins.
Data shown are means ± SD from three independent experiments. *p < 0.05 statistically significant by Student’s t test. Quantification of
western blot analysis from at least three independent experiments (p < 0.05) is shown at the bottom of each panel. The dashed line
indicates the dermal-epidermal junction in (A) and the hair follicle in (B). de, dermis; ep, epidermis.AM184 antagonist had an opposite effect and uncleaved
Notch remained unchanged (Figure 6C), suggesting that
miR-184 controls Notch at the level of activation. To
confirm the effect of miR-184 on Notch transcriptional ac-
tivity, we used Hes1-dGFP reporter plasmid that contains a
destabilized GFP under the promoter of Hes1. Flow cytom-
etry analysis showed that transfection with PM184 mimic
resulted in a significant increase inGFP-positive cells, while
themiR-184mutant (C57U)miRNAmimic had an insignif-
icant effect, and the AM184 antagonist had an opposite ef-
fect (Figure 6D). Finally, to test whether Notch activation is
necessary for miR-184-induced differentiation, transfected
KCs were treated with a g-secretase inhibitor (DAPT) that
prevents Notch cleavage and thus the production of active
NICD. As shown in Figures 6E and 6F, miR-184-repression
of K15 and FIH1 was not reversed by DAPT treatment, indi-
cating that this effect is upstream to Notch and most likely
a direct effect. In contrast, miR-184-induced repression of
basal layer genes (p63, K14) and enhancement in spinous
layer genes (K10, Hes1, Hey2) was attenuated in the pres-
ence of DAPT, suggesting that miR-184 acts upstream to
Notch and its effect on differentiation depends on Notch
activation. Altogether, we conclude that miR-184, through
direct repression of K15 and FIH1, induces an exit from
epidermal stemness/proliferation and accelerates Notch-
dependent differentiation (Figure 7).DISCUSSION
Very few studies have described a single miRNA that plays
a potent role in vivo. In the skin, miR-203 was shown to
repress epidermal stemness by targeting p63 (Lena et al.,
2008; Yi et al., 2008), while miR-24 induced epidermal
cytoskeletal remodeling, differentiation, and cell-cell adhe-
sion (Amelio et al., 2012). In contrast, miR-125b and miR-
205 were shown to be positive regulators of HFSCs (Wang
et al., 2013; Zhang et al., 2011). The present study shows
that miR-184 represses basal layer cell proliferation, in-
hibits p63, and activates Notch in mouse models. In line,
miR-184 repressed clonogenic potential and accelerated
differentiation of human epidermal cells in vitro. Alto-
gether, these observations suggest that miR-184 induces
the commitment to differentiation of basal epidermal cells.
The compartmentalized expression of miR-184 is similar
in the different but closely related epithelial tissues that
were studied, namely, epidermis, hair follicle, and cornea.
miR-184 was low expressed in the SC niche (epidermal
basal layer, bulge, and limbus) but mainly expressed by
cells that migrated out of the niche (epidermal spinous
layer, corneal basal layer, ORS, and matrix of the hair folli-
cle). In the epidermis, the transition from the niche is
coupledwith an exit from the cell cycle. Thus, the elevation
inmiR-184 andNICD in the spinous layer is well correlatedStem Cell Reports j Vol. 9 j 1991–2004 j December 12, 2017 1999
Figure 7. A Working Model
miR-184 regulates the balance between
basal layer cell proliferation and Notch-
dependent differentiation in the epidermis.
By targeting K15 and FIH1, miR-184 induces
the Notch pathway and thereby represses
epidermal stemness, inhibits proliferation,
and induces the differentiation program.with the observed inhibition of proliferation by miR-184.
Although no phenotype has been found yet in the hair fol-
licle of miR-184-KO and transgenic mice, miR-184 and
NICD were both detected in matrix cells that are highly
proliferative, suggesting that miR184/NICD may have a
cell-context-dependent effect on cell proliferation.
The repression of proliferation and activation of Notch
by miR-184 suggests that it may play a role as a tumor
suppressor in the epidermis (Nicolas et al., 2003). Indeed,
miR-184-deficient mice developed a significantly larger
numbers of tumors in a two-stage chemical carcinogenesis
model (S.N. et al., unpublished data). In line, the oncogenic
miR-205 (Cai et al., 2013) is counteracted by competition
with miR-184 (Yu et al., 2008). It was shown that miR-
184 interferes withmiR-205 repression of the phosphatidy-
linositol 3-kinase inhibitor, SHIP2 (Yu et al., 2008, 2010),
and inhibits cell migration (Yu et al., 2010). These studies
link miR-205 with oncogenic properties and its inhibitor,
miR-184, as a tumor suppressor. This is in accordance
with the role of miR-205 in SC maintenance (Wang et al.,
2013) and with our data that miR-184 represses stemness.
It is thus conceivable that some of the functions of miR-
184 that are described in the current study are mediated
by interference with miR-205. Likewise, miR-184 acts as a
tumor suppressor in glioma (Malzkorn et al., 2010) and
neuroblastoma (Foley et al., 2010). However, it was pro-
posed that miR-184 plays a role as an oncogenic miRNA
in head and neck squamous cell carcinoma and in tongue
cancer (Wong et al., 2009), suggesting a context-dependent
role for miR-184 in cancer.
Our data support a model by which miR-184 regulates
Notch activity through repression of K15 and FIH1 (model
in Figure 7). FIH1 is a known repressor of HIF1a (Mahon
et al., 2001) that has been shown to be a negative regulator
ofNotch (Zheng et al., 2008). FIH1 hydroxylates asparagine
residues of proteins containing an ankyrin repeat domain,
including Notch1, IkBa, and p105, while HIF1a is a prom-
inent FIH1 substrate (Cockman et al., 2009). The present
study suggests that FIH1 is required to repress Notch activ-
ity and maintain proliferative potential, while miR-184, by
repressing FIH1, induces the Notch pathway and commit-
ment to differentiation. In agreement, FIH1 is preferen-
tially expressed by LSCs where it regulates cell metabolic2000 Stem Cell Reports j Vol. 9 j 1991–2004 j December 12, 2017status (Peng et al., 2013). In FIH1-null mice, the skin
phenotype has not been described yet. Interestingly, amar-
ginal role was found for FIH1 in the classical aspects of HIF
regulation such as angiogenesis, and, instead, FIH1-null
mice displayed metabolic defects such as reduced body
weight, higher insulin sensitivity, and an elevated meta-
bolic rate (Zhang et al., 2010). In line, miR-184 is involved
in regulating pancreatic b cell growth and function accord-
ing to the demand for insulin (Tattikota et al., 2014). There-
fore, it would be interesting to examine the role for the
miR-184/Notch axis in other tissues where miR-184 is
highly expressed and plays an important role, such as the
cornea and lens (Hughes et al., 2011; Shalom-Feuerstein
et al., 2012) and pancreatic b cells (Tattikota et al., 2014).
Although K15 is considered as a marker of quiescent hair-
follicle and corneal SCs, the regulation of K15 and the func-
tion of K15 remain poorly defined. The expression pattern
of K15 is clearly reciprocal to miR-184, strongly suggesting
that, as soon as cells depart from the niche, the levels
of miR-184 are elevated and, in turn, miR-184 directly
represses K15. Evidently, cytokeratins are not only architec-
tural (structural) proteins. Many studies have demon-
strated their function in cell polarity (Hobbs et al., 2016),
cell proliferation (Depianto et al., 2010), and immunomo-
dulation (Lessard et al., 2013). Previously, it was shown that
K15 can compensate for the loss of K14 in specific types of
stratified epithelia (Lloyd et al., 1995). In the present study,
in vitro knockdown of K15 significantly repressed long-
term proliferation and enhanced differentiation of human
KCs (Figures 5F–5H), suggesting that K15 is important for
epidermal homeostasis. miRNAs may have many target
genes in a given cellular context. Accordingly, the function
of a specific miRNA is mediated by a combinatorial modu-
lation of a set of factors. The data presented here suggest
that miR-184 regulates the balance between epidermal pro-
liferation and differentiation through the repression of K15
and FIH1. However, it is likely that other, yet unknown,
miR-184-target genes are involved in this process.
In line with a previous study by Ryan et al. (2006), the
levels of miR-184 were significantly higher in the cornea
compared with the epidermis and heart (two orders of
magnitude, see Figure S2H). Indeed, point mutations in
miR-184 are linked with autosomal-dominant blinding
eye diseases (Farzadfard et al., 2016; Hughes et al., 2011;
Lechner et al., 2013; Iliff et al., 2012). These patients suffer
from corneal abnormalities and early onset of anterior
cataract (lens opacification). We found that miR-184
is expressed at the highest levels in the corneal and lens
epithelia, high in the hair follicle, and moderately in the
epidermis. To our knowledge, no skin defects were reported
in these patients. miR-184-KOmice displayed corneal stro-
mal thinning, which is in line with keratoconus found in
these patients (to be described elsewhere). Interestingly,
the C57U mutation that is located to the seed sequence
itself (Hughes et al., 2011) resulted in loss-of-function
most likely due to reduced complementary to bona fide
miR-184 target genes such as FIH1 and K15 (Figure 5A),
and failure to induce the Notch pathway and differentia-
tion (Figures 4E and 6D). Future studies will be needed to
define the effect of miR-184 mutation on FIH1, K15, and
on cell proliferation and differentiation in corneal/lens
development, homeostasis, and pathology.EXPERIMENTAL PROCEDURES
Animals Generation and Care
Experiments were performed in accordance with the guidelines
and approval of the local ethical committee (IL-066-05-13). The
miR-184-KO mouse model (C57BL/6N) was generated by Pheno-
min-iCS, Strasbourg. BD10 (MCI-C57BL/6N Tac) embryonic SCs
were electroporated with a construct shown in Figure S1. Five
positive clones were selected out of 372 screened, and following
successful blastocyst injection, germline transmission and in vivo
excision of the Neo cassette by FRP transgene were achieved.
Conditional loxP-miR-184 mice were crossed with ROSA26-Cre
transgene to generate miR-184-HT. Mice were genotyped with
forward (50 ACT GAA CAT TAT TTC ATGGGCCGGG) and reverse
(50 AAC TAC AAC TGT TTG GCT AGC AGG GTG) primers for
the knockout allele or with an alternative reverse primer (50 CGC
TGA GAC CTT GTG ATA AAC CGT T) for the amplification wild-
type allele. Chi-squared test was performed by GraphPad online
software (http://graphpad.com/quickcalcs/chisquared1/).
KRT14-rtTA (genetic background FVB) was purchased from
(008099, The Jackson Laboratory, Bar Harbor, USA) and crossed
with previously described TRE-miR-184Tg (referred to hereafter as
miR-184Tg, genetic background C57BL/6J) (Tattikota et al., 2014).
Dox (TD.01306, Harlan) was administered in the food from E12.
For genotyping, K14-rtTA-specific primers were forward 50-GTC
CGA TGG GAA AGT GTA GCC TG-30 and reverse 50 TTT CTT
CTT TAG CGA CTT GAT GC-30 and miR-184Tg primers were
forward 50 TGC TGA AGA GTG GCC TGC TAG G and reverse
50 CTC CTC CTC ACG TCC TGT GGT A.
Tissue Processing and Staining
Analysis included tissues obtained from three to five mice per ge-
notype from two or more litters. For immunofluorescent staining,
tissues were dehydrated and then stained as detailed previously
(Amitai-Lange et al., 2015). Primary antibodies were rabbit anti-K10 1:400 (Covance, PRB-159P), mouse anti-K14 1:200 (Millipore,
CBL197),mouse anti-FLG1:75 (Abcam,AB31356),mouse anti-P63
1:100 (Santa Cruz, sc-8431), rabbit anti-Ki67 1:100 (Santa Cruz,
sc-7846), mouse anti-K15 1:200 (Santa Cruz, sc-47697), and goat
anti-FIH1 1:100 (Santa Cruz, sc-26219). In situ hybridization was
performed as described previously (Shalom-Feuerstein et al.,
2012). To quantify the percentage of Ki67-positive cells among
DAPI-positive epidermal basal layer cells, a total of 500 cells of
5 different regions on 5 different slides were manually counted
and quantified using ImageJ. Epidermal thickness was measured
by using the line selection tool in ImageJ 1.48v using 10 different
skin regions in each slide and a total of 30 regions were measured.
Similarly, to determine the amount of K14- and K10-positive cells
for each genotype, nuclei of DAPI and K10 or K14 co-stained cells
were counted in epidermal fields thatwere defined for the length of
the dashed lines indicating the dermal-epidermal border.
Cell Culture, Transfections, and In Vitro Assays
KCs and HEK293 were grown as previously described (Lena et al.,
2008). esiRNA reagents were from Sigma-Aldrich and miRNA
mimic/inhibitor were from Ambion. Hes1-dGFP reporter plasmid
was a kind gift from C. Marcello (Rios et al., 2011). For transfec-
tions, we used miRNA mimics and antagonists (50 nM), esiRNA
(15 nM), or Hes1-dGFP (2 mg) with Lipofectamine RNAiMAX
reagent (Invitrogen). The clonogenicity test, reporter assay, and
calcium differentiation were as described (Shalom-Feuerstein
et al., 2012). The P63-30UTR vector was a kind gift from G. Melino
and E. Candi, and FIH1-30UTR was a kind gift from M. Buhler
and O. Lapaire (Lalevee et al., 2014). The epidermis was isolated
from back skin of newborn mice; tissues or cultured cells were
lysed and sonicated in RIPA buffer (Shalom-Feuerstein et al.,
2012) and further prepared as previously described (Shalom-Feuer-
stein et al., 2004, 2008). Real-time PCR analysis was as reported by
Shalom-Feuerstein et al. (2012).
Statistical Analysis
For all measurements, the error bars represent the SDs. Student’s
two-tailed t test was used to determine the respective statistical
significance. Probability (p) values are given in the figure legends;
p < 0.05 was considered statistically significant.
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